...
首页> 外文期刊>Scandinavian journal of urology >Pre-operative risk factors predicting missed diagnosis of renal vein tumor thrombus in renal cell carcinoma: a retrospective cohort study
【24h】

Pre-operative risk factors predicting missed diagnosis of renal vein tumor thrombus in renal cell carcinoma: a retrospective cohort study

机译:预测肾细胞癌中肾静脉肿瘤血栓的错失危险因素:回顾性队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Previous reports showed that some patients with renal cell carcinoma (RCC) and renal vein tumor thrombus (RVTT) were misdiagnosed pre-operatively. To improve the accuracy of this diagnosis, the clinical characteristics of RCC with missed RVTT diagnosis were analyzed. Methods: We retrospectively reviewed RCC patients with RVTT between January 2000 and December 2015. The survival analysis was estimated using the Kaplan-Meier method. The Cox proportional hazard models were applied to identify risk factors. Results: The missed diagnosis rate of RVTT in RCC was 30.5%. In multivariate analysis, maximal tumor diameter, tumor located in the middle part, renal vein contrast agents filling insufficiently and tumor with collateral vessels (odds ratio = 1.22, 1.35, 1.25, 1.22; and p = .034, .003, .015 and .037, respectively) were independent predictors of missed RVTT diagnosis. A missed-diagnosis score was presented as area under curve of 0.852 (p < .001). Moreover, the missed diagnosis group had favorable prognosis, and tumor with collateral vessels was an independent prognostic indicator of poor overall survival time (hazard ratio = 1.15, p = .025). Conclusions: This was the first study exploring clinical features as predictors of missed RVTT diagnosis. The possibility of complicating tumor thrombus should be considered when there is pre-operative presence of tumor with large diameter, renal tumor in the middle part, renal tumor with collateral vessels and renal vein contrast agents filling insufficiently. Patients with three points in missed-diagnosis scoring suggested a high possibility of missed RVTT diagnosis, and tumor with collateral vessels indicated poor prognosis.
机译:目的:之前的报道显示,一些肾细胞癌(RCC)和肾静脉肿瘤血栓(RVTT)的患者预先诊断出来。为提高该诊断的准确性,分析了rcc癌症的临床特征。方法:我们回顾性地审查了2000年1月至2015年12月期间RVTT患者的RCC患者。使用Kaplan-Meier方法估计生存分析。应用Cox比例危险模型来识别风险因素。结果:RCC中的错过诊断率为30.5%。在多变量分析中,位于中间部分的最大肿瘤直径,肿瘤,肾静脉造影剂填充不充分和侧侧血管的肿瘤(差管比率= 1.22,1.22,1.35,1.25,1.22;和P = .034,.003,.015和。 .037分别是错过的RVTT诊断的独立预测因子。错过诊断得分为0.852曲线下的区域(P <.001)。此外,错过的诊断组具有良好的预后,并且侧支血管的肿瘤是整体存活时间差的独立预后指标(危险比= 1.15,P = .025)。结论:这是第一项研究探索临床特征,作为错过的RVTT诊断的预测因子。当肿瘤预呈现大直径的肾肿瘤中,肾脏肿瘤的肾脏肿瘤的肾脏肿瘤患者和肾静脉造影剂填充时,应考虑使肿瘤血栓复杂的可能性。错过诊断评分三点患者表明,未遗产的RVTT诊断的可能性很高,患有侧支血管的肿瘤表明预后差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号